A novel flameless oxidation and in-chamber melting system coupled with advanced scrubbers for a laboratory waste plant.

This is the first study integrate the flameless oxidation (FO) and in-chamber melting (ICM) processes in a primary chamber of a laboratory waste incinerator to improve energy and emission performances. Two liquid burners created a twin-cyclonic fluid field that achieved the FO and ICM in the same chamber. The first cyclone provided a well-mixed and lower temperature FO to reduce auxiliary diesel consumption, NOx and PM emissions by 25.8%, 30.9%, and 79.2%, respectively, from the original system. The hot gases produced by FO enhance the ICM process and transformed the bottom ashes to stabler slags, in turn meeting the regulations for nonhazardous wastes. The other cyclone enhanced the drying and water-gas shift reaction in the drying zone by recirculating the CO and enthalpy from FO and ICM. Eventually, the residual CO, hydrocarbons, and H2 were sent to the secondary chamber for further oxidation. A computational fluid dynamic simulation supported the fluid field assumption posed in this study. Moreover, advanced scrubbers were employed after thermal treatments to reduce HCl and SO2 by 81.8% and 38.8% and further retarded the corrosion rate in the baghouse supporting cage by 87.7%. The precursors of condensable particulate matter were reduced by condensation and finally removed in the baghouse. Nevertheless, the emissions of the high- and mid-molecular-weight polycyclic aromatic hydrocarbons were greatly reduced by 60.8-93.1% and 80.2-99.9%, respectively. Consequently, the new system reduced annual emissions by 40.7-87.6% and operating costs by 41.5%, allowing recovery of the remodification investment in 20.5 months.

Gas-phase isopropanol degradation by nonthermal plasma combined with Mn-Cu/-Al2O3.

In this study, the dielectric barrier discharge (DBD) induced by nonthermal plasma (NTP) technology was used for isopropanol (IPA) degradation. IPA, intermediate, final product, and ozone concentrations were analyzed using GC-MS, carbon dioxide detector, and ozone detector. The experimental flow rate and concentration were fixed to 1 L/min and 1200 ppm ± 10%, respectively. Different reaction procedures were proposed for self-made metal catalyst combined with a plasma system (plasma alone and γ-Al2O3 combined with plasma, Cu (5 wt%)/γ-Al2O3 combined with plasma, Mn (3 wt%)-Cu (5 wt%)/γ-Al2O3 combined with plasma). In addition, the effect of the carrier gas oxygen content (0%, 20%, and 100%) on IPA conversion and intermediate and carbon dioxide selectivity was also investigated. The results revealed that the Mn (F)-Cu/γ-Al2O3 combined with plasma exhibited more efficient IPA conversion. In the 100% oxygen environment, the IPA conversion rate increased from 79.32 to 99.99%, and carbon dioxide selectivity increased from 3.82 to 50.23%. IPA was completely converted after 60 min of plasma treatment with the acetone selectivity, carbon dioxide selectivity, and tail ozone concentration of 26.71% ± 1.27%, 50.23% ± 0.56%, and 1761 ± 11 ppm, respectively. This study proved that the current single planar DBD configuration is an effective advanced treatment technology for the decomposition of VOCs.

Type II Collagen from Cartilage of Acipenser baerii Promotes Wound Healing in Human Dermal Fibroblasts and in Mouse Skin.

Type II collagen is an important component of cartilage; however, little is known about its effect on skin wound healing. In this study, type II collagen was extracted from the cartilage of Acipenser baerii and its effect on in vitro and in vivo wound healing was compared to type I collagen derived from tilapia skin. Sturgeon cartilage collagen (SCC) was composed of α1 chains and with a thermal denaturation (Td) at 22.5 and melting temperature (Tm) at 72.5 °C. Coating SCC potentiated proliferation, migration, and invasion of human dermal fibroblast adult (HDFa) cells. Furthermore, SCC upregulated the gene expression of extracellular matrix (ECM) components (col Iα1, col IIIα1, elastin, and Has2) and epithelial-mesenchymal transition (EMT) molecules (N-cadherin, Snail, and MMP-1) in HDFa. Pretreatment with Akt and mitogen-activated protein kinase (MAPK) inhibitors significantly attenuated the HDFa invasion caused by SCC. In mice, the application of SCC on dorsal wounds effectively facilitated wound healing as evidenced by 40-59% wound contraction, whereas the untreated wounds were 18%. We observed that SCC reduced inflammation, promoted granulation, tissue formation, and ECM deposition, as well as re-epithelialization in skin wounds. In addition, SCC markedly upregulated the production of growth factors in the dermis, and dermal and subcutaneous white adipose tissue; in contrast, the administration of tilapia skin collagen (TSC) characterized by typical type I collagen was mainly expressed in the epidermis. Collectively, these findings indicate SCC accelerated wound healing by targeting fibroblast in vitro and in vivo.